FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global ... as well as mobile robots and other equipment, within one ...

Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6. The target ...

This repository contains the USD Description file for the BD-X robot from Disney. It is derived from the original AWD repository. The license is a NVIDIA License ...

Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two stocks offers value investors a better ...

Carnegie Mellon University and NVIDIA have teamed up to develop a new training technique that enables humanoid robots to ...

Humanoid robotics company Figure AI promised to show "something no one has ever seen" within 30 days, after breaking from ...

Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report first-quarter fiscal 2025 results on Feb. 6, before market open. In the last reported quarter, the company’s ...

BDX's acquisition of Edwards Lifesciences’ Critical Care product group and rising free cash flow are positive indicators for future growth. The stock's momentum is improving, but geopolitical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Barclays analyst Matt Miksic maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $278.00. The company’s shares closed yesterday at $227.21.

In trading on Thursday, shares of Becton, Dickinson & Co (Symbol: BDX) crossed below their 200 day moving average of $233.84, changing hands as low as $232.30 per share. Becton, Dickinson & Co ...